Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer
Although colonoscopy is frequently performed in the United States, there is limited evidence to support threshold values for physician adenoma detection rate as a quality metric. To evaluate the association between physician adenoma detection rate values and risks of postcolonoscopy colorectal cance...
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association Jg. 327; H. 21; S. 2114 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
07.06.2022
|
| Schlagworte: | |
| ISSN: | 1538-3598, 1538-3598 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Although colonoscopy is frequently performed in the United States, there is limited evidence to support threshold values for physician adenoma detection rate as a quality metric.
To evaluate the association between physician adenoma detection rate values and risks of postcolonoscopy colorectal cancer and related deaths.
Retrospective cohort study in 3 large integrated health care systems (Kaiser Permanente Northern California, Kaiser Permanente Southern California, and Kaiser Permanente Washington) with 43 endoscopy centers, 383 eligible physicians, and 735 396 patients aged 50 to 75 years who received a colonoscopy that did not detect cancer (negative colonoscopy) between January 2011 and June 2017, with patient follow-up through December 2017.
The adenoma detection rate of each patient's physician based on screening examinations in the calendar year prior to the patient's negative colonoscopy. Adenoma detection rate was defined as a continuous variable in statistical analyses and was also dichotomized as at or above vs below the median for descriptive analyses.
The primary outcome (postcolonoscopy colorectal cancer) was tumor registry-verified colorectal adenocarcinoma diagnosed at least 6 months after any negative colonoscopy (all indications). The secondary outcomes included death from postcolonoscopy colorectal cancer.
Among 735 396 patients who had 852 624 negative colonoscopies, 440 352 (51.6%) were performed on female patients, median patient age was 61.4 years (IQR, 55.5-67.2 years), median follow-up per patient was 3.25 years (IQR, 1.56-5.01 years), and there were 619 postcolonoscopy colorectal cancers and 36 related deaths during more than 2.4 million person-years of follow-up. The patients of physicians with higher adenoma detection rates had significantly lower risks for postcolonoscopy colorectal cancer (hazard ratio [HR], 0.97 per 1% absolute adenoma detection rate increase [95% CI, 0.96-0.98]) and death from postcolonoscopy colorectal cancer (HR, 0.95 per 1% absolute adenoma detection rate increase [95% CI, 0.92-0.99]) across a broad range of adenoma detection rate values, with no interaction by sex (P value for interaction = .18). Compared with adenoma detection rates below the median of 28.3%, detection rates at or above the median were significantly associated with a lower risk of postcolonoscopy colorectal cancer (1.79 vs 3.10 cases per 10 000 person-years; absolute difference in 7-year risk, -12.2 per 10 000 negative colonoscopies [95% CI, -10.3 to -13.4]; HR, 0.61 [95% CI, 0.52-0.73]) and related deaths (0.05 vs 0.22 cases per 10 000 person-years; absolute difference in 7-year risk, -1.2 per 10 000 negative colonoscopies [95%, CI, -0.80 to -1.69]; HR, 0.26 [95% CI, 0.11-0.65]).
Within 3 large community-based settings, colonoscopies by physicians with higher adenoma detection rates were significantly associated with lower risks of postcolonoscopy colorectal cancer across a broad range of adenoma detection rate values. These findings may help inform recommended targets for colonoscopy quality measures. |
|---|---|
| AbstractList | Although colonoscopy is frequently performed in the United States, there is limited evidence to support threshold values for physician adenoma detection rate as a quality metric.ImportanceAlthough colonoscopy is frequently performed in the United States, there is limited evidence to support threshold values for physician adenoma detection rate as a quality metric.To evaluate the association between physician adenoma detection rate values and risks of postcolonoscopy colorectal cancer and related deaths.ObjectiveTo evaluate the association between physician adenoma detection rate values and risks of postcolonoscopy colorectal cancer and related deaths.Retrospective cohort study in 3 large integrated health care systems (Kaiser Permanente Northern California, Kaiser Permanente Southern California, and Kaiser Permanente Washington) with 43 endoscopy centers, 383 eligible physicians, and 735 396 patients aged 50 to 75 years who received a colonoscopy that did not detect cancer (negative colonoscopy) between January 2011 and June 2017, with patient follow-up through December 2017.Design, Setting, and ParticipantsRetrospective cohort study in 3 large integrated health care systems (Kaiser Permanente Northern California, Kaiser Permanente Southern California, and Kaiser Permanente Washington) with 43 endoscopy centers, 383 eligible physicians, and 735 396 patients aged 50 to 75 years who received a colonoscopy that did not detect cancer (negative colonoscopy) between January 2011 and June 2017, with patient follow-up through December 2017.The adenoma detection rate of each patient's physician based on screening examinations in the calendar year prior to the patient's negative colonoscopy. Adenoma detection rate was defined as a continuous variable in statistical analyses and was also dichotomized as at or above vs below the median for descriptive analyses.ExposuresThe adenoma detection rate of each patient's physician based on screening examinations in the calendar year prior to the patient's negative colonoscopy. Adenoma detection rate was defined as a continuous variable in statistical analyses and was also dichotomized as at or above vs below the median for descriptive analyses.The primary outcome (postcolonoscopy colorectal cancer) was tumor registry-verified colorectal adenocarcinoma diagnosed at least 6 months after any negative colonoscopy (all indications). The secondary outcomes included death from postcolonoscopy colorectal cancer.Main Outcomes and MeasuresThe primary outcome (postcolonoscopy colorectal cancer) was tumor registry-verified colorectal adenocarcinoma diagnosed at least 6 months after any negative colonoscopy (all indications). The secondary outcomes included death from postcolonoscopy colorectal cancer.Among 735 396 patients who had 852 624 negative colonoscopies, 440 352 (51.6%) were performed on female patients, median patient age was 61.4 years (IQR, 55.5-67.2 years), median follow-up per patient was 3.25 years (IQR, 1.56-5.01 years), and there were 619 postcolonoscopy colorectal cancers and 36 related deaths during more than 2.4 million person-years of follow-up. The patients of physicians with higher adenoma detection rates had significantly lower risks for postcolonoscopy colorectal cancer (hazard ratio [HR], 0.97 per 1% absolute adenoma detection rate increase [95% CI, 0.96-0.98]) and death from postcolonoscopy colorectal cancer (HR, 0.95 per 1% absolute adenoma detection rate increase [95% CI, 0.92-0.99]) across a broad range of adenoma detection rate values, with no interaction by sex (P value for interaction = .18). Compared with adenoma detection rates below the median of 28.3%, detection rates at or above the median were significantly associated with a lower risk of postcolonoscopy colorectal cancer (1.79 vs 3.10 cases per 10 000 person-years; absolute difference in 7-year risk, -12.2 per 10 000 negative colonoscopies [95% CI, -10.3 to -13.4]; HR, 0.61 [95% CI, 0.52-0.73]) and related deaths (0.05 vs 0.22 cases per 10 000 person-years; absolute difference in 7-year risk, -1.2 per 10 000 negative colonoscopies [95%, CI, -0.80 to -1.69]; HR, 0.26 [95% CI, 0.11-0.65]).ResultsAmong 735 396 patients who had 852 624 negative colonoscopies, 440 352 (51.6%) were performed on female patients, median patient age was 61.4 years (IQR, 55.5-67.2 years), median follow-up per patient was 3.25 years (IQR, 1.56-5.01 years), and there were 619 postcolonoscopy colorectal cancers and 36 related deaths during more than 2.4 million person-years of follow-up. The patients of physicians with higher adenoma detection rates had significantly lower risks for postcolonoscopy colorectal cancer (hazard ratio [HR], 0.97 per 1% absolute adenoma detection rate increase [95% CI, 0.96-0.98]) and death from postcolonoscopy colorectal cancer (HR, 0.95 per 1% absolute adenoma detection rate increase [95% CI, 0.92-0.99]) across a broad range of adenoma detection rate values, with no interaction by sex (P value for interaction = .18). Compared with adenoma detection rates below the median of 28.3%, detection rates at or above the median were significantly associated with a lower risk of postcolonoscopy colorectal cancer (1.79 vs 3.10 cases per 10 000 person-years; absolute difference in 7-year risk, -12.2 per 10 000 negative colonoscopies [95% CI, -10.3 to -13.4]; HR, 0.61 [95% CI, 0.52-0.73]) and related deaths (0.05 vs 0.22 cases per 10 000 person-years; absolute difference in 7-year risk, -1.2 per 10 000 negative colonoscopies [95%, CI, -0.80 to -1.69]; HR, 0.26 [95% CI, 0.11-0.65]).Within 3 large community-based settings, colonoscopies by physicians with higher adenoma detection rates were significantly associated with lower risks of postcolonoscopy colorectal cancer across a broad range of adenoma detection rate values. These findings may help inform recommended targets for colonoscopy quality measures.Conclusions and RelevanceWithin 3 large community-based settings, colonoscopies by physicians with higher adenoma detection rates were significantly associated with lower risks of postcolonoscopy colorectal cancer across a broad range of adenoma detection rate values. These findings may help inform recommended targets for colonoscopy quality measures. Although colonoscopy is frequently performed in the United States, there is limited evidence to support threshold values for physician adenoma detection rate as a quality metric. To evaluate the association between physician adenoma detection rate values and risks of postcolonoscopy colorectal cancer and related deaths. Retrospective cohort study in 3 large integrated health care systems (Kaiser Permanente Northern California, Kaiser Permanente Southern California, and Kaiser Permanente Washington) with 43 endoscopy centers, 383 eligible physicians, and 735 396 patients aged 50 to 75 years who received a colonoscopy that did not detect cancer (negative colonoscopy) between January 2011 and June 2017, with patient follow-up through December 2017. The adenoma detection rate of each patient's physician based on screening examinations in the calendar year prior to the patient's negative colonoscopy. Adenoma detection rate was defined as a continuous variable in statistical analyses and was also dichotomized as at or above vs below the median for descriptive analyses. The primary outcome (postcolonoscopy colorectal cancer) was tumor registry-verified colorectal adenocarcinoma diagnosed at least 6 months after any negative colonoscopy (all indications). The secondary outcomes included death from postcolonoscopy colorectal cancer. Among 735 396 patients who had 852 624 negative colonoscopies, 440 352 (51.6%) were performed on female patients, median patient age was 61.4 years (IQR, 55.5-67.2 years), median follow-up per patient was 3.25 years (IQR, 1.56-5.01 years), and there were 619 postcolonoscopy colorectal cancers and 36 related deaths during more than 2.4 million person-years of follow-up. The patients of physicians with higher adenoma detection rates had significantly lower risks for postcolonoscopy colorectal cancer (hazard ratio [HR], 0.97 per 1% absolute adenoma detection rate increase [95% CI, 0.96-0.98]) and death from postcolonoscopy colorectal cancer (HR, 0.95 per 1% absolute adenoma detection rate increase [95% CI, 0.92-0.99]) across a broad range of adenoma detection rate values, with no interaction by sex (P value for interaction = .18). Compared with adenoma detection rates below the median of 28.3%, detection rates at or above the median were significantly associated with a lower risk of postcolonoscopy colorectal cancer (1.79 vs 3.10 cases per 10 000 person-years; absolute difference in 7-year risk, -12.2 per 10 000 negative colonoscopies [95% CI, -10.3 to -13.4]; HR, 0.61 [95% CI, 0.52-0.73]) and related deaths (0.05 vs 0.22 cases per 10 000 person-years; absolute difference in 7-year risk, -1.2 per 10 000 negative colonoscopies [95%, CI, -0.80 to -1.69]; HR, 0.26 [95% CI, 0.11-0.65]). Within 3 large community-based settings, colonoscopies by physicians with higher adenoma detection rates were significantly associated with lower risks of postcolonoscopy colorectal cancer across a broad range of adenoma detection rate values. These findings may help inform recommended targets for colonoscopy quality measures. |
| Author | Kim, Eric J Jensen, Christopher D Ghai, Nirupa R Chubak, Jessica Zhao, Wei K Halm, Ethan A Udaltsova, Natalia Ziebell, Rebecca A Fireman, Bruce H Quesenberry, Charles P Lee, Jeffrey K Kamineni, Aruna Sugg-Skinner, Celette Corley, Douglas A Contreras, Richard Schottinger, Joanne E |
| Author_xml | – sequence: 1 givenname: Joanne E surname: Schottinger fullname: Schottinger, Joanne E organization: Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California – sequence: 2 givenname: Christopher D surname: Jensen fullname: Jensen, Christopher D organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 3 givenname: Nirupa R surname: Ghai fullname: Ghai, Nirupa R organization: Department of Quality and Systems of Care, Kaiser Permanente Southern California, Pasadena – sequence: 4 givenname: Jessica surname: Chubak fullname: Chubak, Jessica organization: Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle – sequence: 5 givenname: Jeffrey K surname: Lee fullname: Lee, Jeffrey K organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 6 givenname: Aruna surname: Kamineni fullname: Kamineni, Aruna organization: Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle – sequence: 7 givenname: Ethan A surname: Halm fullname: Halm, Ethan A organization: Simmons Comprehensive Cancer Center and Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas – sequence: 8 givenname: Celette surname: Sugg-Skinner fullname: Sugg-Skinner, Celette organization: Simmons Comprehensive Cancer Center and Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas – sequence: 9 givenname: Natalia surname: Udaltsova fullname: Udaltsova, Natalia organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 10 givenname: Wei K surname: Zhao fullname: Zhao, Wei K organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 11 givenname: Rebecca A surname: Ziebell fullname: Ziebell, Rebecca A organization: Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle – sequence: 12 givenname: Richard surname: Contreras fullname: Contreras, Richard organization: Research and Evaluation, Kaiser Permanente Southern California, Pasadena – sequence: 13 givenname: Eric J surname: Kim fullname: Kim, Eric J organization: Simmons Comprehensive Cancer Center and Department of Population & Data Sciences, University of Texas Southwestern Medical Center, Dallas – sequence: 14 givenname: Bruce H surname: Fireman fullname: Fireman, Bruce H organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 15 givenname: Charles P surname: Quesenberry fullname: Quesenberry, Charles P organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 16 givenname: Douglas A surname: Corley fullname: Corley, Douglas A organization: Division of Research, Kaiser Permanente Northern California, Oakland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35670788$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkDtPwzAUhS1URB-wMiKPLCm24_gxVqE8pEpUCNQxunYdNVVil9gd-u-JoEic5Z6j8-kOZ4pGPniH0C0lc0oIfdhDB3NGGJsLwfkFmtAiV1leaDX658doGuOeDKK5vELjvBCSSKUmaLOIMdgGUhM8DjVe706xGbLHi63zoQP86JKzP_U7JBfxpkk7vA4x2dAGH6INhxMuB98PGLS4BG9df40ua2ijuznfGfp8Wn6UL9nq7fm1XKwyyIs8ZZzXVBKntARLBCFOG7FltOZEF2YoGDW5BmO0roUymjura2nBckWEBsXZDN3__j304evoYqq6JlrXtuBdOMaKCckJKZRkA3p3Ro-mc9vq0Dcd9Kfqbwz2Dbw3Y2M |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1001/jama.2022.6644 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1538-3598 |
| ExternalDocumentID | 35670788 |
| Genre | Multicenter Study Journal Article |
| GroupedDBID | --- -ET -~X .55 .XZ 0R~ 0WA 186 18M 29J 2CT 2FS 2KS 2WC 354 39C 4.4 53G 5GY 5RE 6TJ 85S AAIKC AAMNW AAQQT AAWTL ABBLC ABCQX ABEHJ ABIVO ABOCM ABPMR ABPPZ ABRSH ABWJO ACAHW ACGFS ACNCT ACPRK ACQAM ADBBV ADUKH ADXHL AFCHL AFFNX AFRAH AGHSJ AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU ARBJA BKOMP BRYMA C45 CGR CJ0 CS3 CUY CVF EAM EBD EBS ECM EIF EJD EMOBN EX3 F5P H13 HF~ KOO KQ8 L7B MVM N4W N9A NEJ NPM OBH OCB OGEVE OHH OMK OVD P2P PQQKQ RAJ RNS SJN SV3 TEORI TN5 UHB UKR UPT VVN WH7 WOW X7M XHN XSW XZL YFH YOC YPV YQT YQY YR2 YR5 YSK YYM YZZ ZCA ~H1 7X8 |
| ID | FETCH-LOGICAL-a353t-44f170e897ac0600e9b6d21f4095b70e21b39abb99f68b94ec9f7cac48069a842 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 93 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000812264900020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1538-3598 |
| IngestDate | Fri Sep 05 11:53:49 EDT 2025 Mon Jul 21 05:59:36 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 21 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a353t-44f170e897ac0600e9b6d21f4095b70e21b39abb99f68b94ec9f7cac48069a842 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/9175074 |
| PMID | 35670788 |
| PQID | 2674005872 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2674005872 pubmed_primary_35670788 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-06-07 20220607 |
| PublicationDateYYYYMMDD | 2022-06-07 |
| PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-07 day: 07 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAMA : the journal of the American Medical Association |
| PublicationTitleAlternate | JAMA |
| PublicationYear | 2022 |
| References | 35670806 - JAMA. 2022 Jun 7;327(21):2088-2089. doi: 10.1001/jama.2022.3822 36268617 - J Urol. 2023 Jan;209(1):286-287. doi: 10.1097/JU.0000000000003020 36219411 - JAMA. 2022 Oct 11;328(14):1462. doi: 10.1001/jama.2022.14311 36089052 - Gastroenterology. 2022 Dec;163(6):1714-1715. doi: 10.1053/j.gastro.2022.09.004 36219412 - JAMA. 2022 Oct 11;328(14):1461. doi: 10.1001/jama.2022.14308 |
| References_xml | – reference: 36219412 - JAMA. 2022 Oct 11;328(14):1461. doi: 10.1001/jama.2022.14308 – reference: 36268617 - J Urol. 2023 Jan;209(1):286-287. doi: 10.1097/JU.0000000000003020 – reference: 36219411 - JAMA. 2022 Oct 11;328(14):1462. doi: 10.1001/jama.2022.14311 – reference: 36089052 - Gastroenterology. 2022 Dec;163(6):1714-1715. doi: 10.1053/j.gastro.2022.09.004 – reference: 35670806 - JAMA. 2022 Jun 7;327(21):2088-2089. doi: 10.1001/jama.2022.3822 |
| SSID | ssj0000137 |
| Score | 2.6493597 |
| Snippet | Although colonoscopy is frequently performed in the United States, there is limited evidence to support threshold values for physician adenoma detection rate... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 2114 |
| SubjectTerms | Adenocarcinoma - diagnosis Adenocarcinoma - pathology Adenoma - diagnosis Aged Colonoscopy - adverse effects Colonoscopy - standards Colorectal Neoplasms - diagnosis Colorectal Neoplasms - pathology Early Detection of Cancer - methods Early Detection of Cancer - standards Female Humans Male Middle Aged Retrospective Studies |
| Title | Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35670788 https://www.proquest.com/docview/2674005872 |
| Volume | 327 |
| WOSCitedRecordID | wos000812264900020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qRLz4_TG_iOC12qZpk5xkTIcHN4ao260kWYI72M6tCv735mUt20UQvJRAKQ0vLy-_95HfQ-gKKOhUSGygrdUBJc5nVYlIAyOYSmxEE-Nvub4-sl6PD4eiXwXcZlVZZW0TvaEeFRpi5DckZRR64DFyO_kIoGsUZFerFhqrqBE7KANazYZ8iT7Kc2b6TQ1MdTVp44J1iJDr1CGC3-GlP2Y62_-d4A7aqgAmbs01YhetmHwPbXSrFPo-GiwtCC4s7tehDdxyJqh4l_jOlL4-K8dPAETxYFy-YWjqCwTXeQH3WL5x243BWLpftUFxpgfopXP_3H4Iqu4KgYyTuAwotRELDRdM6tDBHiNUOiKRdQ5fotwLEqlYSKWEsClXghotLNNSUx6mQnJKDtFaXuTmGGHrDn2HezmJaUwtt0KJSKdSOF8G8BNrostaZJnTXkhJyNwUn7NsIbQmOprLPZvMaTayOEmBioif_OHrU7QJi-lruNgZali3d805Wtdf5Xg2vfBq4Z69fvcHg53Bag |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+Physician+Adenoma+Detection+Rates+With+Postcolonoscopy+Colorectal+Cancer&rft.jtitle=JAMA+%3A+the+journal+of+the+American+Medical+Association&rft.au=Schottinger%2C+Joanne+E&rft.au=Jensen%2C+Christopher+D&rft.au=Ghai%2C+Nirupa+R&rft.au=Chubak%2C+Jessica&rft.date=2022-06-07&rft.eissn=1538-3598&rft.volume=327&rft.issue=21&rft.spage=2114&rft_id=info:doi/10.1001%2Fjama.2022.6644&rft_id=info%3Apmid%2F35670788&rft_id=info%3Apmid%2F35670788&rft.externalDocID=35670788 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-3598&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-3598&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-3598&client=summon |